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Background: Although guidelines recommend surgery for high risk patients (p) with multivessel disease (left main, proximal anterior descending, 
2 o 3 proximal vessel disease with large ischemic area or LVEF<0,50), many of them undergo percutaneous coronary intervention (PCI). Incidence of 
major cardiac and cerebrovascular events (MACCE) of these procedures, particularly at institutions without on-site surgical facilities, remains under-
reported.
Methods: All p with class I surgical indication evaluated from September 2003 to April 2010 at a non-cardiac surgery center were studied. Those 
with previous coronary by-pass surgery, acute myocardial infarction (MI) and additional non-coronary surgical indications were excluded. Of 1598 
consecutive p, 418 (26%) underwent PCI, were included in the study and prospectively followed at 30-days and 1-year.
Results: Complete follow-up was achieved for 99% of population (male: 82%, mean age: 70 years, diabetics: 41%). Total mortality rate at 
30-days and 1-year were 3% and 5.5%, respectively. There was not a significant increase in mortality rate between patients that needed new 
revascularization vs. those who did not (RR: 0.70; [95% CI: 0.23 to 3.07]; p=0.649). Table 1 summarized the cumulative incidence of events.
Conclusions: Mid-term outcomes of PCI for surgery class I indications at a non-cardiac surgery center appears to be as low as previously reported 
in surgery registries. New revascularizations were not associated with a higher mortality rate.
Table 1. In-Hospital 30-Days 1-Year
Cardiac death 5/418 (1,2%) 7/418 (1,6%) 13/415 (3,1%)
Non-Cardiac death 2/418 (0,5%) 6/418 (1,4%) 10/415 (2,4%)
Myocardial Infarction 9/418 (2,1%) 9/418 (2,1%) 12/415 (2,9%)
Q-wave/Total MI 3/9 3/9 4/12
Stroke 1/418 (0,2%) 3/418 (0,7%) 4/415 (0,9%)
Target vessel revasc. 1/418 (0,2%) 7/418 (1.6%) 41/415 (9,8%)
MACCE 15/418 (3,5%) 18/418 (4,3%) 66/415 (16,0%)
